British American Tobacco p.l.c. (BTI)
Official siteCONSUMER DEFENSIVE • TOBACCO • NYSE
Market Cap: $132.94B
Last updated: Nov 17, 2026 at 11:05 AM ET
British American Tobacco p.l.c. (BTI) Financials: Revenue, Profit and Cash Flow
British American Tobacco p.l.c. reported revenue of GBP 25.61B for the fiscal year ended Dec 31, 2025, down 1.0% from the year before. That year, net income was GBP 7.76B with a net margin of 30.3%, operating cash flow was GBP 6.34B and free cash flow was GBP 5.79B. The quarter ended Jun 30, 2026 had revenue of GBP 12.33B and net income of GBP 3.21B.
Revenue and Margins
The operating margin was 39.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from GBP 14.13B, a compound annual rate of 6.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 25.61B | -1.0% | 83.5% | 39.0% | 30.3% |
| Dec 2024 | 25.87B | -5.2% | 82.9% | 10.6% | 11.9% |
| Dec 2023 | 27.28B | -1.3% | 82.1% | -57.7% | -52.7% |
| Dec 2022 | 27.66B | +7.7% | 82.6% | 38.1% | 24.1% |
| Dec 2021 | 25.68B | -0.4% | 82.1% | 39.8% | 26.5% |
| Dec 2020 | 25.78B | -0.4% | 82.7% | 38.6% | 24.8% |
| Dec 2019 | 25.88B | +5.7% | 82.8% | 40.2% | 22.0% |
| Dec 2018 | 24.49B | +25.2% | 81.2% | 41.0% | 24.6% |
| Dec 2017 | 19.56B | +38.5% | 74.3% | 36.6% | 191.8% |
| Dec 2016 | 14.13B | N/A | 73.6% | 37.2% | 32.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 152.8% from the year before. In the quarter ended Jun 2026, net income fell 28.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.61B | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B | 25.88B | 24.49B | 19.56B | 14.13B |
| Cost of revenue | 4.23B | 4.44B | 4.89B | 4.80B | 4.60B | 4.45B | 4.46B | 4.60B | 5.03B | 3.73B |
| Gross profit | 21.38B | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B | 21.42B | 19.89B | 14.53B | 10.40B |
| Research and development | 133.00M | 380.00M | 408.00M | 323.00M | 304.00M | 307.00M | 376.00M | 105.00M | 191.00M | 144.00M |
| Operating income | 10.00B | 2.74B | -15.75B | 10.52B | 10.23B | 9.96B | 10.41B | 10.03B | 7.17B | 5.26B |
| Net income | 7.76B | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B | 5.70B | 6.03B | 37.53B | 4.65B |
| EBITDA | 12.03B | 7.74B | 36.64B | 12.58B | 11.19B | 11.80B | N/A | 10.58B | 30.51B | N/A |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.33B | 13.54B | 12.07B | 13.53B | 12.34B | 13.84B | 6.92B | 13.44B | 6.72B | 7.39B | 7.39B | 6.43B |
| Gross profit | 7.28B | 11.30B | 10.09B | 11.26B | 10.18B | 11.20B | 5.60B | 11.20B | 5.60B | 10.48B | 6.78B | 6.52B |
| Operating income | 4.71B | 4.93B | 5.07B | -1.52B | 4.26B | -21.69B | 3.35B | 5.93B | 2.97B | 5.20B | 3.74B | 3.02B |
| Net income | 3.21B | 3.25B | 4.51B | -1.42B | 4.49B | -18.33B | -9.17B | 3.96B | 1.97B | 4.76B | 2.74B | 1.18B |
Balance Sheet
As of Dec 2025, total debt of GBP 34.69B exceeded cash and equivalents by 30.87B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 109.29B | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B | 141.00B | 146.34B | 141.04B | 39.77B |
| Current assets | 12.68B | 14.29B | 14.19B | 15.41B | 12.81B | 13.61B | 13.27B | 12.65B | 13.97B | 12.36B |
| Cash and equivalents | 3.83B | 5.30B | 4.66B | 3.45B | 2.81B | 3.14B | 2.53B | 2.60B | 3.29B | 2.20B |
| Total liabilities | 61.15B | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B | 76.84B | 80.65B | 80.01B | 31.37B |
| Short-term debt | 3.36B | 4.31B | 4.32B | 4.41B | 3.99B | 4.04B | 7.09B | 3.75B | 4.98B | 3.01B |
| Long-term debt | 31.33B | 32.64B | 35.04B | 38.35B | 35.67B | 39.93B | 37.38B | 43.28B | 44.02B | 16.47B |
| Shareholder equity | 47.93B | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B | 63.90B | 65.44B | 60.80B | 8.18B |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108.39B | 109.29B | 110.23B | 118.90B | 119.37B | 119.37B | 118.72B | 118.72B | 146.07B | 146.07B | 153.55B | 153.55B |
| Total liabilities | 59.79B | 61.15B | 63.05B | 68.90B | 64.90B | 64.90B | 65.78B | 65.78B | 73.44B | 73.44B | 77.84B | 77.84B |
| Cash and equivalents | 2.52B | 3.83B | 4.40B | 5.30B | 5.93B | 5.93B | 2.36B | 4.66B | 3.68B | 3.68B | 3.45B | 3.45B |
| Shareholder equity | 48.38B | 47.93B | 46.87B | 49.64B | 54.11B | 54.11B | 52.57B | 52.57B | 72.30B | 72.30B | 75.37B | 75.37B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 91.3% of operating cash flow. Dividends came to 88.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.34B | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B | 9.00B | 10.29B | 5.35B | 4.61B |
| Capital expenditures | 551.00M | 608.00M | 460.00M | 656.00M | 745.00M | 755.00M | 815.00M | 758.00M | 791.00M | 586.00M |
| Free cash flow | 5.79B | 9.52B | 10.25B | 9.74B | 8.97B | 9.03B | 8.18B | 9.54B | 4.56B | 4.02B |
| Dividends paid | 5.12B | 5.21B | 5.11B | 4.92B | 4.90B | 4.75B | 4.60B | 4.35B | 3.46B | 2.91B |
| Investing cash flow | 1.39B | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M | -639.00M | -1.02B | -18.54B | -640.00M |
| Financing cash flow | -8.76B | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B | -8.59B | -9.63B | 14.76B | -4.23B |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.60B | 3.42B | 2.31B | 3.48B | 3.17B | 7.34B | 3.67B | 3.38B | 1.69B | 4.34B |
| Capital expenditures | 134.99M | 448.00M | 103.00M | 492.00M | 116.00M | 350.00M | 175.00M | 110.00M | 55.00M | 256.28M |
| Free cash flow | 2.47B | 2.98B | 2.21B | 2.99B | 3.05B | 6.99B | 3.49B | 3.27B | 1.63B | 4.08B |
Frequently Asked Questions About BTI
What is British American Tobacco p.l.c.'s annual revenue?
British American Tobacco p.l.c. reported revenue of GBP 25.61B for the fiscal year ended Dec 31, 2025.
How fast is British American Tobacco p.l.c.'s revenue growing?
Revenue was down 1.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.5%.
Is British American Tobacco p.l.c. profitable?
Yes. British American Tobacco p.l.c. reported net income of GBP 7.76B for the fiscal year ended Dec 31, 2025, with a net margin of 30.3%.
How much free cash flow does BTI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of GBP 6.34B minus capital expenditures of GBP 551.00M produced free cash flow of GBP 5.79B.
How much debt does British American Tobacco p.l.c. have?
The balance sheet dated Dec 31, 2025 reported long-term debt of GBP 31.33B, short-term debt of GBP 3.36B and cash and equivalents of GBP 3.83B.
BTI pages: Overview, Dividends, Financials